Skip to main content

PDE7A (catalytic domain) (human), (recombinant)

BML-SE524

  • BML-SE524-0020   —   20 µg
    $622.00

PDE7A is expressed in immune and pro-inflammatory cells. It is being investigated as an alternate target to PDE4 for the inhibition of inflammation that is associated with many inflammatory diseases including asthma, chronic obstructive pulmonary disease, atopic dermatitis, psoriasis, lupus, rheumatoid arthritis and multiple sclerosis.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only